<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TEST" NEWID="21480" OLDID="19956" TOPICS="YES">
<DATE>19-OCT-1987 08:49:10.75</DATE>
<TOPICS><D>earn</D></TOPICS>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F 
   f0863 reute
r f BC-LYPHOMED-INC-&lt;LMED.O&gt;   10-19 0067</UNKNOWN>
<TEXT> 
<TITLE>LYPHOMED INC &lt;LMED.O&gt; 3RD QTR NET</TITLE>
<DATELINE>    ROSEMONT, ILL., Oct 19 -
    </DATELINE><BODY>Shr 18 cts vs 13 cts
    Net 5,436,000 vs 3,888,000
    Sales 43.9 mln vs 31.5 mln
    Avg shrs 30,145,000 vs 28,976,000
    Nine mths
    Shr 51 cts vs 38 cts
    Net 15,320,000 vs 11,098,000
    Sales 123.6 mln vs 91.2 mln
    Avg shrs 30,157,000 vs 29,046,000
    NOTE: Earnings adjusted for three-for-two stock split paid
June 20, 1986
 Reuter
 </BODY></TEXT>
</REUTERS>